121 related articles for article (PubMed ID: 30602500)
1. Low Expression of the Androgen-Induced Tumor Suppressor Gene
Stopsack KH; Gerke T; Tyekucheva S; Mazzu YZ; Lee GM; Chakraborty G; Abida W; Mucci LA; Kantoff PW
Cancer Epidemiol Biomarkers Prev; 2019 Apr; 28(4):707-714. PubMed ID: 30602500
[TBL] [Abstract][Full Text] [Related]
2. PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy.
Hsieh CL; Botta G; Gao S; Li T; Van Allen EM; Treacy DJ; Cai C; He HH; Sweeney CJ; Brown M; Balk SP; Nelson PS; Garraway LA; Kantoff PW
Cancer Res; 2015 May; 75(10):1944-8. PubMed ID: 25808865
[TBL] [Abstract][Full Text] [Related]
3. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S
Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071
[TBL] [Abstract][Full Text] [Related]
4. Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4.
Dahal S; Chaudhary P; Kim JA
Cell Oncol (Dordr); 2023 Aug; 46(4):1113-1126. PubMed ID: 36995683
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral Sterol-27-Hydroxylase (
Khan NA; Stopsack KH; Allott EH; Gerke T; Giovannucci EL; Mucci LA; Kantoff PW
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1052-1058. PubMed ID: 30867220
[TBL] [Abstract][Full Text] [Related]
6. PLZF mediates the PTEN/AKT/FOXO3a signaling in suppression of prostate tumorigenesis.
Cao J; Zhu S; Zhou W; Li J; Liu C; Xuan H; Yan J; Zheng L; Zhou L; Yu J; Chen G; Huang Y; Yu Z; Feng L
PLoS One; 2013; 8(12):e77922. PubMed ID: 24339862
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of PLZF as a prostatic androgen-responsive gene.
Jiang F; Wang Z
Prostate; 2004 Jun; 59(4):426-35. PubMed ID: 15065091
[TBL] [Abstract][Full Text] [Related]
8. Expression of the PTEN/FOXO3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression.
Zhang Q; Li X; Li Y; Chen S; Shen X; Dong X; Song Y; Zhang X; Huang K
Invest New Drugs; 2020 Apr; 38(2):321-328. PubMed ID: 31087222
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients.
Brunner G; Reitz M; Schwipper V; Tilkorn H; Lippold A; Biess B; Suter L; Atzpodien J
Cancer Biother Radiopharm; 2008 Aug; 23(4):451-9. PubMed ID: 18771349
[TBL] [Abstract][Full Text] [Related]
10. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2.
Shen H; Zhan M; Zhang Y; Huang S; Xu S; Huang X; He M; Yao Y; Man M; Wang J
Cell Death Dis; 2018 Jan; 9(2):71. PubMed ID: 29358655
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk Between Prostate Cancer Cells and Tumor-Associated Fibroblasts Enhances the Malignancy by Inhibiting the Tumor Suppressor PLZF.
Noh KH; Jeong AJ; Lee H; Lee SH; Yi E; Chang PS; Kwak C; Ye SK
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32349303
[TBL] [Abstract][Full Text] [Related]
12. Androgen promotes differentiation of PLZF
Wang J; Li J; Xu W; Xia Q; Gu Y; Song W; Zhang X; Yang Y; Wang W; Li H; Zou K
Cell Commun Signal; 2019 May; 17(1):57. PubMed ID: 31142324
[TBL] [Abstract][Full Text] [Related]
13. Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.
Elfandy H; Armenia J; Pederzoli F; Pullman E; Pertega-Gomes N; Schultz N; Viswanathan K; Vosoughi A; Blattner M; Stopsack KH; Zadra G; Penney KL; Mosquera JM; Tyekucheva S; Mucci LA; Barbieri C; Loda M
Mol Cancer Res; 2019 Feb; 17(2):446-456. PubMed ID: 30333152
[TBL] [Abstract][Full Text] [Related]
14. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
Ahearn TU; Pettersson A; Ebot EM; Gerke T; Graff RE; Morais CL; Hicks JL; Wilson KM; Rider JR; Sesso HD; Fiorentino M; Flavin R; Finn S; Giovannucci EL; Loda M; Stampfer MJ; De Marzo AM; Mucci LA; Lotan TL
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26615022
[TBL] [Abstract][Full Text] [Related]
16. Role of PLZF as a tumor suppressor in prostate cancer.
Jin Y; Nenseth HZ; Saatcioglu F
Oncotarget; 2017 Sep; 8(41):71317-71324. PubMed ID: 29050363
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia zinc finger is involved in the formation of deep layer cortical neurons.
Lin HC; Ching YH; Huang CC; Pao PC; Lee YH; Chang WC; Kao TJ; Lee YC
J Biomed Sci; 2019 Apr; 26(1):30. PubMed ID: 31027502
[TBL] [Abstract][Full Text] [Related]
19. Deregulated expression of promyelocytic leukemia zinc finger protein in B-cell chronic lymphocytic leukemias does not affect cyclin A expression.
Parrado A; Noguera ME; Delmer A; McKenna S; Davies J; Le Gall I; Bentley P; Whittaker JA; Sigaux F; Chomienne C; Padua RA
Hematol J; 2000; 1(1):15-27. PubMed ID: 11920165
[TBL] [Abstract][Full Text] [Related]
20. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
